FEATURED ARTICLES

• Showcasing Advances In CAR-T Research At The 65th ASH Annual Meeting

  Take a look at three research posters presented at the 65th American Society of Hematology (ASH) annual meeting, emphasizing the impact of academic-industry collaborations on CAR-T therapy.

• Enhancing Clinical Trial Diversity Through Stakeholder Engagement

  Review several pertinent barriers that have impeded diversity in clinical studies and the strategies used to overcome them.

• 4 Ways To Increase Diversity In Clinical Trials

  Uncover diversity strategies that encompass every facet of the trial lifecycle, such as the design of a patient-centric experience, proper positioning for regulatory and operational success, and more.

• Validating New Identification Algorithms With Objective Criteria & Clinical Trial Data

  Learn how researchers and clinicians can make better-informed decisions to advance patient care and enhance public health outcomes related to myocardial infarction.

• CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment

  Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.

• Shorten The Path: From Discovery To Approval Of Novel Therapies

  Unearth how this trial design solution was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

• Improving CAR-T Trial Success With Historical Trial Data Optimization

  Breakthroughs in oncology have revolutionized patient care. Dive into treatment access, challenges faced in clinical development, and how data can be utilized to accelerate clinical development.

• Achieving Diversity In Clinical Trials Amidst Regulatory Focus

  Learn about several strategies and best practices when enhancing diversity in clinical trials and advancing healthcare for all ethnic groups.

• New Research On Concurrence Of CRS & ICANS In CAR T-cell Treatments

  Gain insight into the latest advancements in AI-driven investigations, shedding light on the complexities of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapies.

• Enhancing Clinical Trials By Linking Them To RWD

  Learn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.